Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Journey Medical Corp shares valued at $33,065 were sold by Maraoui Claude on May 02 ’25. At $6.84 per share, Maraoui Claude sold 4,834 shares. The insider’s holdings dropped to 2,348,313 shares worth approximately $14.91 million following the completion of this transaction.
Also, Benesch Joseph sold 2,409 shares, netting a total of over 16,478 in proceeds. Following the sale of shares at $6.84 each, the insider now holds 203,557 shares.
Before that, Alloush Ramsey had sold 2,857 shares from its account. In a trade valued at $19,542, the COO traded Journey Medical Corp shares for $6.84 each. Upon closing the transaction, the insider’s holdings decreased to 2,857 shares, worth approximately $3.21 million.
As published in their initiating research note from Rodman & Renshaw on August 22, 2024, Journey Medical Corp [DERM] has been a Buy and the price target has been revised to $9. As of December 07, 2021, B. Riley Securities has initiated its “Buy” rating for DERM.
Analyzing DERM Stock Performance
On last trading session,, Journey Medical Corp [NASDAQ: DERM] rose 0.63% to $6.35. The stock’s lowest price that day was $6.22, but it reached a high of $6.58 in the same session. During the last five days, there has been a drop of approximately -8.10%. Over the course of the year, Journey Medical Corp shares have jumped approximately 62.40%. Shares of the company reached a 52-week high of $8.25 on 06/02/25 and a 52-week low of $3.54 on 01/22/25.
Support And Resistance Levels for Journey Medical Corp (DERM)
According to the 24-hour chart, there is a support level at 6.19, which, if violated, would cause prices to drop to 6.02. In the upper region, resistance lies at 6.55. The next price resistance is at 6.74. RSI (Relative Strength Index) is 38.72 on the 14-day chart, showing neutral technical sentiment.
Is Journey Medical Corp subject to short interest?
Stocks of Journey Medical Corp saw a sharp rise in short interest on 2025-05-30 jumping by 61325.0 shares to 0.39 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.33 million shares. A jump of 15.58% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.97 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.97.
Which companies own the most shares of Journey Medical Corp (DERM)?
In terms of Journey Medical Corp share price expectations, FactSet research, analysts set an average price target of 10.5 in the next 12 months, up nearly 66.4% from the previous closing price of $6.31. Analysts anticipate Journey Medical Corp stock to reach 10.5 by 2025, with the lowest price target being 10.5. In spite of this, 1 analysts ranked Journey Medical Corp stock as Buy at the end of 2025.
